The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


GSK Vaccines S.r.l.EU/1/10/614/002-003

Main Information

Trade NameMenveo
Active SubstancesMeningococcal group y oligosacchardie
Meningococcal group a oligosaccharide
Meningococcal group c oligosaccharide
Meningococcal group w-135 oligosaccharide
Dosage FormPowder and solution for solution for injection
Licence HolderGSK Vaccines S.r.l.
Licence NumberEU/1/10/614/002-003

Group Information

ATC CodeJ07AH Meningococcal vaccines
J07AH08 meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated


License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back